Digoxin Antikörper (AbBy Fluor® 647)
-
- Target Alle Digoxin (DIG) Produkte
- Digoxin (DIG)
- Reaktivität
- Bitte anfragen
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Digoxin Antikörper ist konjugiert mit AbBy Fluor® 647
-
Applikation
- Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität (Details)
- Digoxin
- Aufreinigung
- Purified by Protein A.
- Immunogen
- BSA conjugated to Dig
- Isotyp
- IgG
-
-
- Applikationshinweise
- IF(IHC-P) 1:50-200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- Digoxin (DIG)
- Andere Bezeichnung
- Digoxin (DIG Produkte)
- Substanzklasse
- Chemical
- Hintergrund
-
Synonyms: Digoxigenin, Lanoxin.
Background: Digoxin is a beta blocker drug originally derived from the foxglove plant, Digitalis lanata. Digoxin is used primarily to improve the pumping ability of the heart in congestive heart failure (CHF), and treat problems such as high blood pressure. It is also used to help normalize some dysrhythmias (abnormal types of heartbeat).
-